D
vTv Therapeutics Inc. VTVT
$22.74 $7.8953.13%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Weiss Ratings VTVT - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Rating D
Reward Index Very Weak
Risk Index Weak
Risk Grade D
Reward Grade E
Rating Factors VTVT - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Dividend Index --
Growth Index Weak
Efficiency Index Very Weak
Solvency Index Excellent
Total Return Index Weak
Volatility Index Weak
Beta / Standard Deviation VTVT - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Beta 1.11
Price History VTVT - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
7-Day Total Return 47.75%
30-Day Total Return 44.66%
60-Day Total Return 46.99%
90-Day Total Return 62.43%
Year to Date Total Return 67.55%
1-Year Total Return 13.02%
2-Year Total Return -25.20%
3-Year Total Return -15.35%
5-Year Total Return -65.12%
52-Week High % Change -26.62%
52-Week Low % Change 87.62%
Price VTVT - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
52-Week High Price $30.99
52-Week Low Price $12.12
52-Week Low Price (Date) Jul 29, 2024
52-Week High Price (Date) Mar 21, 2024
Valuation VTVT - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Market Cap 59.40M
Enterprise Value 20.86M
Price/Earnings (TTM) --
Earnings Per Share (TTM) -7.63
Earnings Per Share Growth -26.47%
Price/Earnings To Growth --
Price/Sales (TTM) 59.40
Price/Book (Q) 3.96
Enterprise Value/Revenue (TTM) 20.86
Price $22.74
Enterprise Value/EBITDA (TTM) -0.87
Enterprise Value/EBIT -0.87
Market Cap Category Micro Cap
Dividends and Shares VTVT - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Shares Outstanding 2.61M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info VTVT - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Phone Number 336 841 0300
Address 3980 Premier Drive High Point, NC 27265
Website vtvtherapeutics.com
Country United States
Year Founded 2015
Profitability VTVT - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Operating Margin (TTM) -2,399.50%
Profit Margin -1,830.60%
Management Effectiveness VTVT - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Return on Assets -51.64%
Return on Equity --
Income Statement VTVT - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Revenue (TTM) 1.00M
Total Revenue (TTM) 1.00M
Revenue Per Share $0.38
Gross Profit (TTM) -7.23M
EBITDA (TTM) -23.91M
EBIT (TTM) -24.00M
Net Income (TTM) -18.31M
Net Income Avl. to Common (TTM) -18.31M
Total Revenue Growth (Q YOY) --
Earnings Growth (Q YOY) 31.62%
EPS Diluted (TTM) -7.63
EPS Diluted Growth (Q YOY) 42.63%
Balance Sheet VTVT - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash and Short-Term Inv. (Q) 41.66M
Cash Per Share (Q) $15.95
Total Current Assets (Q) 42.96M
Total Preferred Equity (Q) --
Total Equity (Q) 17.91M
Current Ratio (Q) 6.687
Book Value Per Share (Q) $5.75
Total Assets (Q) 43.16M
Total Current Liabilities (Q) 6.42M
Total Debt (Q) 213.00K
Total Liabilities (Q) 25.25M
Total Common Equity (Q) 15.01M
Cash Flow VTVT - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash from Investing (TTM) 4.40M
Cash from Financing (TTM) 52.33M
Net Change in Cash (TTM) 33.33M
Levered Free Cash Flow (TTM) -15.40M
Cash from Operations (TTM) -23.40M
Weiss Ratings